• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21045 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2018     NIHR Health Services and Delivery Research programme Understanding new models of care in local contexts: a systematic review using frameworks to examine pathways of change, applicability, and generalisability of the international research evidence
2020     NIHR Health Services and Delivery Research programme Understanding how frontline staff use patient experience data for service improvement - an exploratory case study evaluation and national survey (US-PEx)
2021     NIHR Health Technology Assessment programme Understanding health-care outcomes of older people with cognitive impairment and/or dementia admitted to hospital: a mixed-methods study
2018     NIHR Health Services and Delivery Research programme Understanding employee whistleblowing in health care
2020     NIHR Health Services and Delivery Research programme Understanding and improving experiences of care in hospital for people living with dementia, their carers and staff: three systematic reviews
2019     NIHR Health Services and Delivery Research programme Understanding and enhancing how hospital staff learn from and act on patient experience data
1990     U. S. Congress. Office of Technology Assessment (OTA) Unconventional cancer treatments
2001     Alberta Heritage Foundation for Medical Research (AHFMR) Uncomplicated senile cataract surgeries in Alberta
2010     Adelaide Health Technology Assessment (AHTA) Unattended sleep studies in the diagnosis and reassessment of obstructive sleep apnoea
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Umeclidinium/vilanterol (as trifenatate) (Anoro® Ellipta®)
2012     NIHR Horizon Scanning Centre (NIHR HSC) Umeclidinium and vilanterol for chronic obstructive pulmonary disease
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Umeclidinium (Incruse®)
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Umbilical cord clamp removal: a review of the clinical benefits and harms
2013     HAYES, Inc. Umbilical cord blood stem cell transplantation for hematological cancers and nonmalignant disorders in children
2013     HAYES, Inc. Umbilical cord blood stem cell transplantation for hematological and lymphoid malignancies in adults
2005     HAYES, Inc. Umbilical cord blood stem cell transplantation
2002     HAYES, Inc. Umbilical cord blood stem cell transplantation
2011     HAYES, Inc. Ultroid hemorrhoid management system (Ultroid Technologies Inc.)
2009     Medical Advisory Secretariat (MAS) Ultraviolet phototherapy management of moderate-to-severe plaque psoriasis: an evidence-based analysis
2013     Malaysian Health Technology Assessment (MaHTAS) Ultraviolet Germicidal Irradiation (UVGI) indoor purifier – an update
2010     HAYES, Inc. Ultraviolet B phototherapy for vitiligo
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Ultrasound-guided sclerotherapy with foam in chronic vein insufficiency
2001     HAYES, Inc. Ultrasound-guided percutaneous breast biopsy
2012     HAYES, Inc. Ultrasound-guided injections of joints of the extremities
2014     HAYES, Inc. Ultrasound-guided injections of joints of the extremities
2016     HAYES, Inc. Ultrasound-guided high-intensity focused ultrasound for primary treatment of localized prostate cancer
2006     National Institute for Health and Clinical Excellence (NICE) Ultrasound-guided foam sclerotherapy for varicose veins
2007     National Institute for Health and Clinical Excellence (NICE) Ultrasound-guided foam sclerotherapy for varicose veins
2011     HAYES, Inc. Ultrasound-Guided Foam Sclerotherapy (UGFS) for varicose veins
2007     HAYES, Inc. Ultrasound-enhanced transcutaneous drug delivery
1999     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ultrasound-assisted lipoplasty
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Ultrasound versus computed tomography for children with suspected appendicitis: clinical evidence, cost-effectiveness, and guidelines
1997     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Ultrasound treatment - systematic review
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Ultrasound treatment - nonunion fractures
2014     HAYES, Inc. Ultrasound transient elastography for detecting hepatic fibrosis in patients with hepatitis C
2003     ECRI Ultrasound screening of normal-risk women for prevention of postterm pregnancy
2000     NIHR Health Technology Assessment programme Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views
2003     Adelaide Health Technology Assessment (AHTA) Ultrasound screening for hip dysplasia: a new screening programme for the early detection of hip dysplasia in neonates
2006     Medical Advisory Secretariat (MAS) Ultrasound screening for abdominal aortic aneurysm: an evidence-based analysis
2001     Centre for Clinical Effectiveness (CCE) Ultrasound or venogram for diagnosis of deep vein thrombosis (DVT)?
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Ultrasound of peripheral nerves
2004     Malaysian Health Technology Assessment Unit (MHTAU) Ultrasound in primary and antenatal care
2004     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Ultrasound in pregnancy - Evaluation of the routine ultrasound examinations according to the German Maternity Code
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ultrasound imaging in the practice of anaesthesia
2012     HAYES, Inc. Ultrasound guidance to aid in the placement of peripherally inserted central catheter lines
2007     Adelaide Health Technology Assessment (AHTA) Ultrasound for assessment of risk of fracture
2000     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Ultrasound diagnostic during pregnancy
2003     Institute for Clinical Systems Improvement (ICSI) Ultrasound cervical length for the prediction of preterm labor
2015     HAYES, Inc. Ultrasound bone growth stimulation
2003     HAYES, Inc. Ultrasound bone growth stimulation
2009     HAYES, Inc. Ultrasound bone growth stimulation
2000     ECRI Ultrasound bone densitometry for diagnosis of osteoporosis
2016     Health Quality Ontario (HQO) Ultrasound as an adjunct to mammography for breast cancer screening: OHTAC recommendation
2016     Health Quality Ontario (HQO) Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment
2002     Blue Cross Blue Shield Association (BCBS) Ultrasonography of peripheral sites for selecting patients for pharmacologic treatment for osteoporosis
1998     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Ultrasonography in primary health care. IPE-98/16 (Public report)
2014     Malaysian Health Technology Assessment (MaHTAS) Ultrasonic wound debridement device
2014     Agenzia nazionale per i servizi sanitari regionali (Agenas) Ultrasonic energy devices for surgery
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Ultrasonic cutting and coagulating devices
2015     Health Quality Ontario (HQO) Ultrafiltration in heart failure: a rapid review
2013     HAYES, Inc. Ultrafiltration in congestive heart failure
2008     VA Technology Assessment Program (VATAP) Ultrafiltration for heart failure
2010     VA Technology Assessment Program (VATAP) Ultrafiltration for decompensated heart failure
2006     NIHR Horizon Scanning Centre (NIHR HSC) Ultrafiltration for acute decompensated heart failure: horizon scanning technology briefing
2007     HAYES, Inc. Ultrafiltration for acute decompensated congestive heart failure
2003     Adelaide Health Technology Assessment (AHTA) Ultrafast magnetic resonance imaging (MRI) for patients undergoing conventional MRI
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ultra-low-dose Danazol (Optina; Vasaloc) for diabetic macular oedema
2015     Adelaide Health Technology Assessment (AHTA) Ultra-filtration for patients with decompensated heart failure
2022     NIHR Health Technology Assessment programme Ulipristal acetate versus conventional management of heavy menstrual bleeding (HMB; including uterine fibroids): a randomised controlled trial and exploration of mechanism of action (UCON trial)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ulipristal Acetate (Fibristal - Actavis Specialty Pharmaceuticals Co.) indication: uterine fibroids
2016     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ulipristal acetate (Esmya®)
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ulipristal acetate (Esmya®)
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ularitide for acute decompensated heart failure – first line
2020     NIHR Health Services and Delivery Research programme UK Study of tendon Achilles Rehabilitation multicentre randomised clinical trial (UK STAR)
2018     NIHR Health Technology Assessment programme UK Lung Cancer Screening Trial (UKLS) - Feasibility study and protocol development
1995     NIHR Health Technology Assessment programme UK home parenteral nutrition register
2016     NIHR Health Technology Assessment programme UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2016     NIHR Health Technology Assessment programme UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2015     NIHR Health Technology Assessment programme UK DRAFFT: a randomised controlled trial of percutaneous fixation with Kirschner wires versus volar locking-plate fixation in the treatment of adult patients with a dorsally displaced fracture of the distal radius
2021     NIHR Health Technology Assessment programme UK Cohort study to Investigate the prevention of Parastomal Hernia (CIPHER)
2010     HAYES, Inc. UGT1A1 Sequence Variant Testing for Predicting Response to Irinotecan Therapy in Colorectal Cancer
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors, immune checkpoint inhibitors and everolimus for treating advanced renal cell cancer
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors for treating MET mutation-positive metastatic non-small-cell lung cancer
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors for treating ALK mutation-positive advanced non-small-cell lung cancer
2014     Malaysian Health Technology Assessment (MaHTAS) Typhoid carrier test (Typhidot-C)
2012     NIHR Health Technology Assessment programme Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antisepticimpregnated urethral catheters (the CATHETER trial)
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Type 2 diabetes. Health technology assessment of screening, diagnosis and treatment
2004     National Institute for Clinical Excellence (NICE) Type 2 diabetes: Prevention and management of foot problems
2004     National Institute for Clinical Excellence (NICE) Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults
2017     Agency for Healthcare Research and Quality (AHRQ) Tympanostomy tubes in children with otitis media
2002     HAYES, Inc. Tympanoplasty for recurrent and chronic otitis media
2006     University HealthSystem Consortium (UHC) Tygacil
2022     Medical Services Advisory Committee (MSAC) Two testing options for determining eligibility for access to Pharmaceutical Benefits Schedule-subsidised aducanumab in patients with early stage Alzheimer disease
2020     NIHR Health Technology Assessment programme Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT
2018     NIHR Health Technology Assessment programme Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study
2012     Medical Advisory Secretariat (MAS) Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis
2014     Health Quality Ontario (HQO) Turning for ulcer reduction (TURN) study: an economic analysis
2014     Health Quality Ontario (HQO) Turning for the prevention and management of pressure ulcers: OHTAC Recommendation
2011     Penn Medicine Center for Evidence-based Practice (CEP) Tunneled vs. non-tunneled catheters for acute hemodialysis
2003     The Swedish Council on Health Technology Assessment (SBU) TUNA - Transurethral needle ablation for BPH - early assessment briefs (Alert)